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Tazarotene’s Knockout Punch
Augusto and coworkers report that daily topical tazarotene cleared 47% of basal cell carcinomas, with no recurrences after 2 years.
Apoptosis increased, epidermal proliferation decreased and necrosis was seen in treated lesions. By activating apoptosis and
decreasing proliferation, tazarotene may have a one-two punch fatal to basal cell carcinoma. J Invest Dermatol 122:1037–1041,
2004.
Skin Biopsy for Fabry Disease Gene Therapy
Biweekly treatment with human recombinant alpha-
galactosidase A cleared globotriosylceramide from
affected internal organs, skin, skin capillaries, and other skin
cells in patients with Fabry disease, as reported by Thurberg and
colleagues. Since skin lesions often occur before internal organ
involvement, the biopsy may be a cost-effective and minimally
invasive technique to monitor therapy and to prevent systemic
disease. J Invest Dermatol 122:900–908, 2004.
Dohi Disease Is Spreading
Dohi disease, named after the modern father of Japanese
dermatology who described it, has symmetrical acral reticulate
pigmentation, and was often considered to be limited to Japan.
Qing and coworkers describe two Chinese families with Dohi
disease and novel adenosine deaminase mutations. Some of
those difficult-to-diagnose pigmentary diseases seen elsewhere
in the world may represent Dohi disease. J Invest Dermatol 122:
896–899, 2004.
Calling All Monozygous Twins
A pair of dichorionic monozygous twins have different hair whorl
patterns. Cockayne summarized some of the genetic studies on
whorls (Inherited Abnormalities of the Skin, Oxford, 1933). Study-
ing the scalp patterns of a large number of twins should be
intriguing, and may help determine the relative roles of nature and
nurture on whorls; it may also yield important clues to the early
developmental events that determine skin structure and pattern-
ing. J Invest Dermatol 122:1057–1058, 2004.
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